Evidence map›Paper›PMID 41854070›Full record

ArticleNucleic acids research2026

An RNA structural switch controlling bacterial toxin translation.

Athina Eleftheraki, Andrés Escalera-Maurer, Elsa D M Hien, Alice Virciglio, Maéva Conangle, Nicolas J Tourasse, Anaïs Le Rhun, Erik Holmqvist

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Athina EleftherakiDepartment of Cell and Molecular Biology, Biomedical Center, Uppsala University, Uppsala S-75124, Sweden.ORCID 0009-0002-9424-0314
Andrés Escalera-MaurerUniv. Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, Bordeaux F-33000, France.ORCID 0000-0002-2660-262X
Elsa D M HienDepartment of Cell and Molecular Biology, Biomedical Center, Uppsala University, Uppsala S-75124, Sweden.ORCID 0009-0009-4318-5643
Alice VirciglioUniv. Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, Bordeaux F-33000, France.ORCID 0009-0005-3812-4919
Maéva ConangleUniv. Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, Bordeaux F-33000, France.ORCID 0009-0006-6065-8965
Nicolas J TourasseUniv. Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, Bordeaux F-33000, France.ORCID 0009-0007-7379-8729
Anaïs Le RhunUniv. Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, Bordeaux F-33000, France.ORCID 0000-0003-2211-2153
Erik HolmqvistDepartment of Cell and Molecular Biology, Biomedical Center, Uppsala University, Uppsala S-75124, Sweden.ORCID 0000-0001-7834-1487

Funding

InsermSwedish Research CouncilSwedish Research Council 2021-04657The Wenner-Gren FoundationsUppsala Antibiotic Centre
6 · The paper itself

Abstract

Type I toxin-antitoxin systems (T1TAs) rely on tight posttranscriptional control to prevent inadvertent toxin synthesis, yet the molecular mechanisms underlying this control are highly diverse. Here, we uncover an RNA-based mechanism that controls translation initiation in the enterobacterial timPR system. Unlike most T1TAs, which typically rely on ribonucleolytic messenger RNA (mRNA) processing to relieve ribosome binding site sequestration, the primary timP toxin mRNA is activated through a purely structural RNA switch. Using a FASTBAC-Seq loss-of-function screen with biochemical and phenotypic assays, we here identify key RNA interactions that govern this switch. Translation initiation at timP requires formation of (i) a pseudoknot in the 5' untranslated region, and (ii) a long-range interaction that destabilizes the ribosome-binding-site-sequestering stem-loop, rendering the Shine-Dalgarno sequence accessible for pre-initiation complex formation. Conversely, an alternative interaction locks the mRNA in an inactive state. Our findings reveal a structural RNA switch that controls toxin expression without the need for enzymatic processing and demonstrate an alternative mechanism for translation initiation in bacteria.

Indexed as

Bacterial ToxinsPeptide Chain Initiation, TranslationalRNA, BacterialRNA, MessengerToxin-Antitoxin Systems5' Untranslated RegionsBacterial ProteinsBinding SitesGene Expression Regulation, BacterialNucleic Acid ConformationRibosomes5' Untranslated RegionsBacterial ProteinsBacterial ToxinsRNA, BacterialRNA, Messenger

Identifiers

PMID41854070
PMCPMC13000454

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.